Get started
Author

Gorkem Oztosun

ORCID: 0000-0002-8374-4405
Observed ORCID: 0000-0002-8374-4405
OpenAlex ID: A5114594983
Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas
2025 · Gorkem Oztosun, Amy Armstrong, et al. · Expert Opinion on Investigational Drugs · 12
MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al. · Clinical Cancer Research · 7
PDF
DDDR-59. Focal Adhesion Kinase (FAK) Inhibitor Synergizes with RAF/MEK inhibitor in Malignant Peripheral Nerve Sheath Tumors with Chromosome 8 Gain
2025 · Dana Borcherding, Guangfeng Wang, et al. · Neuro-Oncology · 1
PDF
Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors
2026 · Guangfeng Wang, Dana C. Borcherding, et al. · Journal of Clinical Investigation
PDF
Multi-omics integration of malignant peripheral nerve sheath tumors nominates therapies based on chromosome 8q status
2026 · Belinda B. Garana, Jiawan Wang, et al. · Research Square
Multi-omics integration of malignant peripheral nerve sheath tumors identifies potential targets based on chromosome 8q status
2026 · Belinda B. Garana, Jiawan Wang, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Germline MRAS Variant in an Infant With Bilateral Adrenal Neuroblastoma
2026 · Gorkem Oztosun, Eric Hawley, et al. · Pediatric Blood & Cancer
PDF
Data from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 4 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 3 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 6 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 2 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 1 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
Supplemental Figure 5 from MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al.
DDDR-64. MTA-Cooperative PRMT5 Inhibitors Demonstrate Efficacy in MTAP-Deleted MPNST Models and Enhance Chemotherapy Response
2025 · xiaochun zhang, Dana Borcherding, et al. · Neuro-Oncology
PDF
Exth-62. Focal Adhesion Kinase (fak) in Chromosome 8 Gain-associated Malignant Peripheral Nerve Sheath Tumors (mpnst)
2024 · Guangfeng Wang, Dana Borcherding, et al. · Neuro-Oncology
PDF
Tmod-26. Generation of a Chromosome 8 Gain;nf1-/- Hipsc-derived Schwann Cell Precursor Model
2024 · Gorkem Oztosun, Simge Acar, et al. · Neuro-Oncology
PDF
Works count: 17
Citation count: 20
H-index: 2
I10-index: 1
Year
Topic
Type